Karcinom Merklovih celic
Merkel cell carcinoma

Authors

  • Darja Eržen Onkološki inštitut, Ljubljana

Keywords:

the Merkel cell carcinoma, neuroendocrine skin carcinoma

Abstract

Karcinom Merklovih celic (MCC) je redek, agresiven in pogosto smrten nevroendokrini kožni karcinom. Zanimanje zanj se v zadnjem času veča zaradi naraščanja incidence in možne virusne povezave. V prispevku so opisani klinična slika, zamejitveni sistem in zdravljenje ter izkušnje Onkološkega inštituta Ljubljana (OIL). Prikazan je pregled serije 40 bolnikov, zdravljenih na OIL od 1994 do 2011.

Abstract (Eng)

The Merkel Cell Carcinoma (MCC) is a rare, aggressive and often deadly neuroendocrine skin carcinoma. Recently, there has been a growing interest in this type of cancer due to its increasing incidence and possible viral connection. The article presents the clinical picture, staging system, treatment and experience of the Institute of Oncology Ljubljana (IOL). Also included is a review of 40 patients treated at the IOL from 1994 to 2011.

Downloads

Published

2012-06-15

How to Cite

Eržen, D. (2012). Merkel cell carcinoma. Onkologija : Slovenian Journal of Oncology, 16(1), 14–17. Retrieved from https://revijaonkologija.si/Onkologija/article/view/220

Issue

Vol. 16 No. 1 (2012)

Section

Review Article

License

The journal is published under the terms of the Creative Commons Attribution License CC-BY 4.0. The authors retain the copyright to their work without any restrictions whatsoever.

This journal is an open-access journal, meaning that all of its contents are freely accessible without any charge to the user or their institution. In accordance with the Budapest Open Access Initiative (BOAI) definition of open access, users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking for prior permission from the publisher or the author, provided the authors and the journal are appropriately credited.